Literature DB >> 9752968

Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta.

M J McKenna1, A G Kristiansen, M L Bartley, J J Rogus, J L Haines.   

Abstract

HYPOTHESIS: Otosclerosis is related to mild osteogenesis imperfecta with genetic defects in type I collagen.
BACKGROUND: Otosclerosis is a common bone disease of the human otic capsule that has an underlying hereditary predisposition. The histopathology and clinical manifestations are strikingly similar to the milder forms of osteogenesis imperfecta in which mutations of type I collagen genes have been established as the underlying cause.
METHODS: The authors investigated the genetic basis of otosclerosis by conducting an association study using polymorphic DNA markers from patients with clinical otosclerosis and random control subjects.
RESULTS: This study showed a significant association between clinical otosclerosis and the type I collagen COL1A1 gene using three different polymorphic markers within the gene.
CONCLUSIONS: Some cases of clinical otosclerosis may be related to mutations within the COL1A1 gene that are similar to those found in mild forms of osteogenesis imperfecta and result in null expression of the mutant allele.

Entities:  

Mesh:

Year:  1998        PMID: 9752968

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  18 in total

Review 1.  Etiopathogenesis of otosclerosis.

Authors:  Tamás Karosi; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

2.  Does otosclerosis affect the dimensions of the facial canal and cochlear aquaduct?

Authors:  Vefa Cakmak; Pinar Cakmak
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-06       Impact factor: 2.503

3.  Differences in gene expression between the otic capsule and other bones.

Authors:  Konstantina M Stankovic; Osamu Adachi; Kunikazu Tsuji; Arthur G Kristiansen; Joe C Adams; Vicki Rosen; Michael J McKenna
Journal:  Hear Res       Date:  2010-02-08       Impact factor: 3.208

4.  No evidence for disturbed COL1A1 and A2 expression in otosclerosis.

Authors:  Péter Csomor; Balázs Liktor; Bálint Liktor; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-01       Impact factor: 2.503

5.  Transgenic mice expressing a ligand-inducible cre recombinase in osteoblasts and odontoblasts: a new tool to examine physiology and disease of postnatal bone and tooth.

Authors:  Jung-Eun Kim; Kazuhisa Nakashima; Benoit de Crombrugghe
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 6.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

7.  Association of bone morphogenetic proteins with otosclerosis.

Authors:  Isabelle Schrauwen; Melissa Thys; Kathleen Vanderstraeten; Erik Fransen; Nele Dieltjens; Jeroen R Huyghe; Megan Ealy; Mireille Claustres; Cor R W J Cremers; Ingeborg Dhooge; Frank Declau; Paul Van de Heyning; Robert Vincent; Thomas Somers; Erwin Offeciers; Richard J H Smith; Guy Van Camp
Journal:  J Bone Miner Res       Date:  2008-04       Impact factor: 6.741

8.  Genetic variants in the RELN gene are associated with otosclerosis in multiple European populations.

Authors:  Isabelle Schrauwen; Megan Ealy; Erik Fransen; Kathleen Vanderstraeten; Melissa Thys; Nicole C Meyer; Marcel Cosgarea; Alex Huber; Manuela Mazzoli; Markus Pfister; Richard J H Smith; Guy Van Camp
Journal:  Hum Genet       Date:  2009-10-22       Impact factor: 4.132

9.  Gene expression analysis of human otosclerotic stapedial footplates.

Authors:  Megan Ealy; Wenjie Chen; Gi-Yung Ryu; Jae-Geun Yoon; D Bradley Welling; Marlan Hansen; Anup Madan; Richard J H Smith
Journal:  Hear Res       Date:  2008-03-15       Impact factor: 3.208

10.  Rare variants in BMP2 and BMP4 found in otosclerosis patients reduce Smad signaling.

Authors:  Megan Ealy; Nicole C Meyer; Johnny Cruz Corchado; Isabelle Schrauwen; Andreas Bress; Markus Pfister; Guy Van Camp; Richard J H Smith
Journal:  Otol Neurotol       Date:  2014-03       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.